Cancer is the most common disease worldwide, with death often occurring as a result of metastasis. Thus, interfering with metastasis has been regarded as a promising strategy to improve the current cancer treatments. However, exploration and development of novel anti-metastatic agents remains a major challenge. Recent evidence indicated that a polysaccharide isolated from Taxus yunnanensis suppressed tumor cells proliferation. With the objective of seeking bioactive extracts, we had previously isolated, purified and characterized a complex, water-soluble polysaccharides, PSY-1, from the leaves of Taxus chinensis var. mairei, and identified its anti-neoplastic effects. In this study, we focused on the effects of PSY-1 on cancer metastasis and its mechanism(s). The results illustrated that PSY-1 effectively suppressed the migration and invasion ability of the melanoma cancer cell line B16-F10, caused down-regulation of MMP-2 and MMP-9, and that the NF-κB pathway was involved in the anti-metastatic effects imposed by PSY-1.
Metastasis, one of the most demonstrated hallmarks of cancer, is responsible for more than 90 percent of cancer-associated mortality in clinics [1] . Until now, efficient therapeutics to fight against metastasis were lacking. As an intricate process, cancer metastasis involves sequential and interrelated multi-steps, which, in principle, are the same for nearly all categories of tumors [2] . Generally, to execute metastasis, a cancer cell at the primary site first invades the surrounding tissue, enters the micro-vascular system, then translocates through and exits the bloodstream, and finally adapts to and thrives within the foreign microenvironment [1] . Loss of cellcell or cell-matrix adhesion molecules, such as E-cadherin, and the acquisition of MMPs (matrix metalloproteinases, which are able to degrade the extracellular matrix) are significant for intravasation of cancer cells. Naturally, such stages are basic and critical for antimetastasis drug screening.
Natural products never fail to be an indispensable source of anticancer agents. More than 110,000 natural agents were screened for their potential anti-cancer activity in an NCI-launched-project from 1958 to 1980. Through this project, Paclitaxel, which was obtained from the bark of Taxus brevifolia, was soon discovered for its remarkable cytotoxic effects. Until now, Paclitaxel has been approved by a number of countries for the treatment of breast cancer [4] , ovarian cancer [3] , non-small cell lung carcinoma [5] , bladder cancer [7] , head and neck cancer [6] and a range of other malignancies. In fact, Paclitaxel has been clinically employed as a main constituent of anti-cancer therapy. Major mechanisms of its anti-tumor effects include, but are not limited to, microtubule stabilization [8] , MAPK activation [9] , Bcl-2 phosphorylation [10] and angiogenesis inhibition.
However, worldwide acceptance and the broad-spectrum use of Paclitaxel have not perfected it. A small portion of Paclitaxel can be extracted from tree bark, no industrialized, total-synthesis-route is available for Paclitaxel currently, and limited resources exist for the semi-synthesis of its raw materials, 10-deacetyl baccatin III, for instance, all of which make this drug unaffordable for many cancer patients. Furthermore, its concomitant side effects are as marked as its anti-neoplastic activity. Toxic effects regarding dermatological reactions [11, 12] , bone marrow suppression, hypersensitivity reactions, fluid retention and neurotoxicity [13] were reported. Like virtually all other therapeutic strategies, a majority of cancer patients would finally be non-responsive to Paclitaxel treatment, despite them being of the so-called 'targeted' or 'non-targeted' class [14] .
For decades, studies concerning yew and its anti-cancer activity mainly focused on taxanes, especially Paclitaxel and Docetaxel. T. brevifolia were usually discarded after extraction, which caused environmental contamination as well as resource prodigality. T. chinensis var. mairei (Lemee et Levl) Cheng et L.K. Fu is widely distributed in China and is also a significant source of taxanes. Polysaccharide from T. yunnanensis was reported to show antineoplastic activity [15] , and for the purpose of discovering lesstoxic but still effective constituents, we previously isolated, purified and characterized complex water-soluble polysaccharides from the leaves of T. chinensis var. mairei [16] . Obtained by water and EtOH extraction, total crude polysaccharide was applied to a DEAE-Sepharose FF anion-exchange column for elution. After acid hydrolysis, four homogeneous fractions were acquired, among which PSY-1 (designated as SF1 in [16] ), with a molecular weight of 106 KD, was the most abundant constituent, and showed the most potent anti-cancer activity.
In this study, we furthered our investigation into the anti-neoplastic activity and mechanisms of PSY-1. As demonstrated by wound-healing assay and transwell assays, PSY-1 effectively suppressed the migration of the melanoma cancer cell line B16-F10. Furthermore, we discovered that transcriptional and posttranscriptional levels of MMPs (matrix metalloproteinase) as well as their activities were significantly down-regulated upon PSY-1 treatment. The NF-κB pathway might have been disrupted to execute these anti-migration mechanisms. Our study unfolded the anti-cancer activity and mechanisms of one-component Taxus polysaccharide, which could provide insight for the exploitation of Taxus vegetation.
PSY-1 inhibits the proliferation of tumor cells and HUVEC cells:
To examine the anti-proliferative activities of PSY-1 on a variety of cancer and HUVEC cells, we detected the effect of PSY-1 on the proliferation of the human ovary cancer cell lines A2780 and SKOV-3, human liver cancer cell lines HepG2 and SMMC-7721, human prostatic cancer cell line PC-3, human colon cancer cell line HT-29, mouse melanoma cell line B16-F10 and human umbilical vein endothelial cells HUVEC by exposing them to serial concentrations of PSY-1 for 72 h. The sulforhodamine assay was conducted to calculate the IC 50 values. Taxol was used as the reference drug. As shown in Table 1 , PSY-1 exhibited antiproliferative activity against a variety of tumor and HUVEC cells. The IC 50 values ranged from 1.5 mg/mL to 15.0 mg/mL. 
PSY-1 suppresses the ability of B16-F10 cells migration and invasion in vitro:
As tumor metastasis is a vital factor leading to the death of carcinoma patients, we examined the effect of PSY-1 on B16-F10 cells migration and invasion. In a wound-healing assay, confluent B16-F10 cells were scratched to make a wound, then exposed to gradient concentrations of PSY-1, and the wound width was assessed 24 h later. As illustrated in Figure 1A , FBS stimulated B16-F10 cells to close the wound more than the two groups without PSY-1. In contrast, PSY-1 exposure suppressed the healing of the scratched wound in a concentration-dependent manner as the highest concentration of PSY-1 (5 mg/mL) showed the most inhibition. The results were scored in a double-blind method by analyzing several areas of the wound ( Figure 1B ). Transwell assay was performed to further demonstrate the invasion inhibition effect of PSY-1. As illustrated in Figure 1C , cell migration increased dramatically with medium containing 10% fetal bovine serum (FBS) in the lower chamber when compared with the group without FBS stimulation. In contrast, PSY-1 treatment (1 mg/mL and 5 mg/mL) for 24 h restrained this strong migration by approximately 35% and 50%, respectively ( Figure 1D ).
PSY-1 suppresses invasion of mouse melanoma via downregulation of the MMP level:
The aforementioned results demonstrated the anti-metastatic activities of PSY-1, and thus we were inspired to explore the underlying mechanisms. MMP-2 and MMP-9, both belonging to the MMP family, are known for their capacity for degrading extracellular matrix (ECM), which contributes to cancer cell invasion. After treatment with PSY-1, the functions and the expression levels of MMP-2 and MMP-9 were examined by real-time PCR, Western blotting and MMP zymography assay, respectively. With increased doses of PSY-1, the protein levels of MMP-2 and MMP-9 decreased. To examine whether pre-transcriptional or post-transcriptional processes were intervening, real-time PCR was used, which indicated a negative correlation between the PSY-1 concentration and the relative level of MMP-2 RNA (MMP-2/GAPDH). Because MMP-2 and MMP-9 were reported to be secreted out of the cell to fulfill their tasks as proteinases, we used a zymography assay to confirm the impact of PSY-1 on the extracellular level and activity of these proteins. As shown in Figure 2C , PSY-1 negatively impacted the activated extracellular protein level of MMP-2 and MMP-9. 
PSY-1 decreases MMP level by inhibiting NF-κB cell signaling:
Because PSY-1 can affect the MMP mRNA, protein and secretion levels, we speculated that PSY-1 might disturb the up-stream signal transduction of MMP. Mounting evidence has demonstrated that AKT, MAPK and NF-κB cell signaling pathways are involved in regulating MMPs, and thus we were interested in examining the expression and activation levels of the related proteins. As displayed in Figure 3 , PSY-1 showed little effect on AKT, p38 and ERK levels, as well as their phosphorylated protein levels, while IκB, a suppressive factor of NF-κB, was up-regulated by PSY-1 (1 mg/mL, 5 mg/mL). Through further studies we found that the phosphorylated IκB was decreased simultaneously, which could explain why IκB accumulated in B16-F10 cells. We therefore concluded that administering PSY-1 could inhibit NF-κB cell signaling by protecting IκB from phosphorylation and degradation and, thus, decreasing the MMP level, which inhibits the migration and metastasis of mouse melanoma. When compared with malignant primary tumors, disseminated cells that gain the ability to migrate and invade and seed in distant organs are often the cells that can cause the most harmful effects to patients and cause the vast majority of deaths [18, 19] . However, numerous studies have proven that tumor metastasis is a process with complicated regulators and various influencing factors, from a stepwise accumulation of genetic events to multiple, constant effects from the tumor microenvironment [20] [21] [22] . In recent studies, many researchers focused on the initial process of tumor metastasis in the hope of finding a strategy to stop the progression headstream. Of the related studies, the loss of cell-cell adherence and the degradation of the extracellular matrix (ECM) are the two key events for tumor cells to gain more migration ability and to escape from the primary site [23, 24] . Therefore, MMPs, which can degrade nearly all types of ECM, become vital targets for anti-metastasis therapy [25] .
The matrix metalloproteinases (MMPs) belong to the metzincin superfamily and are divided into various subtypes according to their specialized substrates and differences in structures. Most MMPs are first secreted to the extracellular environment in an inactive form and are then cleaved by activators to gain bioactivity [26] . MMP levels and activity can be regulated through many mechanisms, such as changes in the mRNA level, cell signal transduction and control of the activity of the protease through naturally existing agonists and tissue inhibitors of metalloproteinases (TIMPs) in the body [27, 28] . MMPs, which can eliminate the ECM to provide space for cell proliferation or clear away redundant cells, are very important in fetal formation, ovulation and the wound-healing process in a healthy body. However, recent studies revealed that MMPs participate in tumor metastasis [29] [30] [31] [32] , and related studies demonstrated that MMP-2 and MMP-9 are up-regulated in metastasis tumors [33] [34] [35] and the NF-κB cell signaling is activated [36] [37] [38] .
NF-κB, as an important transcription factor that participates in cell proliferation and transcription regulation of apoptosis-related genes, plays an important role in tumor metastasis [39] . When NF-κB cell signaling is activated, the suppressant molecule will be phosphorylated and dissociated from the NF-κB, and the freed transcription factor translocates into the nucleus and stimulates the transcription of downstream genes [40] . Many studies have illustrated that stimulated NF-κB cell signaling could promote the expression of MMP-9 [41, 42] , and sustained activated NF-κB cell signaling was found in colorectal carcinoma tissue when compared with the normal tissue samples in Kojima et al's study [43] .
In this study, we found that PSY-1, a polysaccharide extracted from Taxus chinensis, can restrain the migration and invasion abilities of B16 cells, and the wound-healing and transwell assays show that exposure to different concentrations of PSY-1 results in inhibition effects of various degrees. In further studies, we uncovered that PSY-1 could influence the expression of two important MMP family members, MMP-2 and MMP-9. We employed Western blotting, real-time quantitative PCR and gelatin zymography assays to detect MMP-2 and MMP-9 expression and activity, and found that the protein level, the mRNA level as well as the protease activities of MMP-2 and MMP-9 were impaired by PSY-1. These observations suggested that PSY-1 might modulate the transcriptional levels of MMP-2 and MMP-9. Consistent with this hypothesis, in an attempt to investigate the underlying mechanism of the inhibition of MMPs, we found that the activated NF-κB cell signaling in B16-F10 cells was prohibited by PSY-1.
To conclude, our current study demonstrated that the extract of Taxus chinensis var. mairei could down-regulate MMP-2 and MMP-9 at the transcription level by inhibiting the NF-κB pathway.
Because of the important role that MMPs play in the tumor metastasis progress, the exploration for MMP inhibitors has become attractive and shown great potential in the treatment of cancer in preclinical studies. In this regard, our study provides some natural material information for discovering MMP inhibitors and aids in the discovery and structure modification of novel MMP inhibitors. In 244 Natural Product Communications Vol. 9 (2) 2014
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addition, our study implies that the polysaccharide extract of T. chinensis, PSY-1, displays an anti-metastasis effect, which may provide research data for further exploitation of this taxon.
Experimental
Cell line and cell culture: B16-F10 cells were purchased from the Institute of Cell Biology in Shanghai and cultured with RPMI-1640 (GIBCO, Grand Island, USA) supplemented with L-glutamine (0.29 mg/mL), kanamycin (0.06 mg/mL) and 10% heat-inactivated fetal bovine serum (FBS). Cells were cultured at 37°C with 5% CO 2 in a humidified atmosphere.
Cell proliferation assay:
Proliferation suppression was determined using the sulforhodamine (SRB) method. Cells were seeded into 96well plates. After overnight incubation, PSY-1 was added to each well at a series of concentrations and incubated for 72 h .The supernatant was then discarded, and the cells were fixed in situ and stained for 30 min at room temperature with SRB (4 mg/ml). The plates were then washed using 1% acetic acid and air dried, and the dye was solubilized with 100 μL/well of 10 mM Tris base. The optical density (OD) was obtained using a Multiskan Spectrum (Thermo Electron Corporation, USA) at a wavelength of 535 nm. IC 50 values were then calculated using the Logit method.
Wound-healing assay: B16-F10 cells in medium containing 10% FBS were seeded into 24-well plates. After the cells grew to confluence, wounds were made using sterile pipette tips. Cells were washed with PBS and refreshed with medium containing different concentrations of PSY-1. After overnight incubation at 37°C, the cells were fixed and photographed with a microscope (DFC300 FX, Leica, Germany).
Transwell assay: B16-F10 cells were incubated in medium without FBS overnight. After seeding the starved cells into the upper compartment of the transwell and filling the lower compartment with medium containing 10% FBS, different concentrations of PSY-1 were added into the upper compartment 1 h later. After incubation at 37°C for 24 h, the cells adhering to the upper layer of the transwell membrane were removed, and the lower layer cells were stained with crystal violet and photographed using a microscope. The 570 nm OD value was recorded after dissolving the crystal violet with 10% ethylic acid.
Real-time quantitative PCR assay:
Total RNA was prepared using the Trizol reagent (Bio Basic Inc., Markham, Ontario, Canada), as recommended by the manufacturer. After isolation and quantification, equal amounts of total RNA were reversetranscribed to cDNA using random hexamer primers and Revert Aid TM M-MuLV Reverse Transcriptase (Fermentas International Inc., Burlington, Ontario, Canada). Equilibrated amounts of cDNA were then used for transcript PCR amplification. Quantitative PCR analysis was performed using the Eppendorf epGradient Mastercycler (Eppendorf, Hamburg, Germany) according to the standardized thermal profile of the system that was previously set by the manufacturer and QuantiTectTM SYBR Green PCR kits (Qiagen Inc., Valencia, CA) were used for detection. The sequences of the primers that were used for the quantitative real time-PCR were as follows: mouseMMP2, 5'-CTTCGCTCGTTTCCTTCAAC-3', 5'-AGAGTGAGGAGGGGAACCAT-3', and GAPDH, 5'TGCACCACCAACTGCTTAGC-3', 5'-GGCATGGACTGTGG TCATGAG-3' [17] . Relative expression levels of the target genes were normalized to the control gene GAPDH.
Western blot analysis: B16-F10 cells were seeded into 6-well plates and incubated overnight. Subsequently, the cells were exposed to different concentrations of PSY-1 (1 mg/mL and 5 mg/mL) and continued incubating for 24 h. After the supernatants were discarded, the cells were lysed in 1×SDS gel loading buffer [50 mmol/L Tris-HCl (pH6.8), 100 mmol/L DTT, 2% SDS, 0.1% bromphenol blue, and 10% glycerol] and then boiled for 5 to 10 min. Samples with equal amounts of cell lysates were loaded and separated on 10% SDS polyacrylamide gels. Proteins on the gel were then electro-transferred to a polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, USA) and probed with primary antibodies and HRP-labeled secondary antibodies. Proteins were visualized using ECL detection reagents (Amersham Biosciences, Piscataway, USA).
Gelatin zymography assay:
Zymography was performed to assess the gelatinolytic activity of MMP-2 and MMP-9. Confluent cells were incubated with serum-free medium with or without PSY-1 (1 mg/mL, 5 mg/mL) for 24 h. Samples of conditioned medium were collected and concentrated, and gel zymography was performed following the protocol of the MMP zymography assay kit (Applygen, CA). Briefly, the serum-free conditioned media were electrophoresed on a 10% SDS polyacrylamide gel impregnated with 1 mg/mL of gelatin under non-reducing conditions. To activate the proteinases, the gels were incubated at 37°C for 24 h in an incubation buffer containing 50 mM Tris-HCl (pH 7.5), 10 mM CaCl 2 , and 0.02 mM NaN 3 . The gels were subsequently fixed and stained with 0.25% Coomassie brilliant blue R-250 for 1 h and washed in destaining solution (25% methanol and 7% acetic acid dissolved in distilled water) to visualize the bands of proteolytic activity. Gel images were analyzed using the NIH Image analysis system (Bio-Rad, USA).
Statistical analysis:
All values were expressed as the mean ± s.d. Each value is the mean of at least 3 separate experiments in each group. The differences in the effects of compound treatment when compared with the vehicle-treated control values were analyzed by an appropriate t-test. * Indicates values that are significantly different than the control (*p<0.05, **p<0.01, ***p<0.001).
Chemicals and reagents:
PSY-1 was extracted as previously described [16] . A stock concentration of PSY-1 (50 mg/mL) was prepared in RPMI-1640 and stored at −20°C. The stock solution was further diluted with the appropriate assay culture medium immediately before use. Primary antibodies for MMP-2 (sc-13595), MMP-9 (sc-58389) and β-actin (sc-1616) were obtained from Santa Cruz Biotechnology (Santa Cruz, USA). Antibodies for p-Akt (#9272), Akt (#9271), p-Erk1/2 (#9101), Erk1/2 (#9102), p-p38 (#9216s) and p38 (#8690s) were purchased from Cell Signaling Technology (Beverly, USA). Secondary antibodies for horseradish peroxidase-conjugated anti-rabbit IgG, anti-goat IgG and anti-mice IgG were purchased from Santa Cruz Biotechnology (Santa Cruz, USA).
